10066- MET-7 RISK FACTORS FOR THE EPILEPSY IN PATIENTS WITH BRAIN METASTASES
Takahiro Sasaki, Yasuo Nakai, Junya Fukai, Naoyuki Nakao · 2024
Read 10066- MET-7 RISK FACTORS FOR THE EPILEPSY IN PATIENTS WITH BRAIN METASTASES by Takahiro Sasaki, Yasuo Nakai, Junya Fukai, Naoyuki Nakao (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11605569.txt.
Description
Seizures strike about one in five patients whose cancer has spread to the brain, Takahiro Sasaki and co-authors report in a 2024 conference abstract. Longer cancer control makes the epilepsy burden harder to ignore. Two hundred patients treated across fourteen years were reviewed for tumor and treatment traits.
Larger tumors, swelling around them, bleeding inside them, surgery, and skipping targeted drugs all tracked higher seizure risk in first-pass tests. Guidelines advise against preventive anti-seizure drugs for all such patients. Sharper risk rules could target prevention to those likeliest to seize, sparing others the side effects. The authors frame where such rules might start.
Catalog record
| CREATOR | Takahiro Sasaki, Yasuo Nakai, Junya Fukai, Naoyuki Nakao |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 1 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |